
|Articles|October 16, 2017
Croda Showcases High-Purity Pharma Excipients at CPhI Worldwide 2017
Author(s)Pharmaceutical Technology Editors
Croda is showcasing its portfolio of high-purity pharmaceutical excipients that can be used to maximize API performance.
Advertisement
Croda, a supplier of natural-based specialty chemicals, is showcasing its portfolio of high-purity pharmaceutical excipients that can be used to maximize API performance at CPhI Worldwide 2017. The company has manufacturing facilities around the globe.
Experts from Croda will be available to talk about the benefits of high-purity pharmaceutical ingredients for multiple drug administration routes, including the parenteral, ophthalmic, oral, and topical routes.
Visitor can visit Croda at CPhI to learn more about:
- Improved API stability
- Reduced cellular irritation
- Increased API delivery
- Accelerated speed to market
- Reducing drug development times
- Simplifying formulations
Source: Croda, Stand 102B11
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
2
Renewing Prosaic Generics for Cancer Treatment
3
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
4
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
5




